Royal Bank of Canada
SCPS

Royal Bank of Canada’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Royal Bank of Canada’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed – – 8167
2022
Q2 		$0 Hold
1,000
– – ﹤0.01% 8088
2022
Q1 		$1K Hold
1,000
– – ﹤0.01% 7671
2021
Q4 		$2K Hold
1,000
– – ﹤0.01% 7456
2021
Q3 		$4K Sell
1,000
-1,056
-51% -$5.44K ﹤0.01% 7231
2021
Q2 		$15K Sell
2,056
-1,536
-43% -$10.9K ﹤0.01% 6724
2021
Q1 		$30K Buy
+3,592
New +$37.6K ﹤0.01% 6204

Other funds holding SCPS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCM
M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Royal Bank of Canada's SCPS Position: Q3 2022 in Review

Royal Bank of Canada sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q3 2022, closing a stake of 1,000 shares.

Royal Bank of Canada first reported a position in SCPS in Q1 2021 and held it in 6 quarters. The position peaked at $30K in Q1 2021. 15 funds tracked by Wall St. Rank hold SCPS as of Q3 2022.

  • Royal Bank of Canada reported no remaining Scopus BioPharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 1,000 Scopus BioPharma Inc. Common Stock shares in Q3 2022.
  • Royal Bank of Canada first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Royal Bank of Canada's Scopus BioPharma Inc. Common Stock position peaked at $30K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q3 2022.

Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.